Molgramostim
Top View
- Production Design of Efficient Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Under a Gene-Specific Promoter in Prokaryotic System
- Hematopoietic Progenitor Cell Mobilization for Autologous Transplantation
- Anatomical Classification Guidelines V2018 EPHMRA ANATOMICAL
- Systematic Review of Randomized Controlled Trials of Hematopoietic Stem Cell Mobilization Strategies for Autologous Transplantat
- The Impact of Biosimilar Competition June 2016 the Impact of Biosimilar Competition Introduction
- Haematological Malignancies
- The Impact of Biosimilar Competition in Europe Contents
- Molgramostim (GM-CSF) Associated with Antibiotic Treatment in Nontraumatic Abdominal Sepsis a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- Innate Immune Modulation by GM-CSF and IL-3 in Health and Disease
- COMP Minutes 17-19 May 2016
- A Randomized Study Comparing Filgrastim Versus Lenograstim Versus Molgramostim Plus Chemotherapy for Peripheral Blood Progenitor
- (Neulasta) in Patients with Sickle Cell Trait/Anemia
- Managing Sarcoma: Where Have We Come from and Where Are We Going?
- New Therapies Haemopoietic Growth Factors
- Perioperative Recombinant Human Granulocyte Colony-Stimulating Factor (Filgrastim) Treatment Prevents Immunoinflammatory Dysfunc
- Synthesis of Granulocyte–Macrophage Colony- Stimulating Factor As Homogeneous Glycoforms and Early Comparisons with Yeast Cell-Derived Material
- Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor: Effect of Glycosylation on Pharmacokinetic Parameters
- A View Into Upcoming Specialty & Traditional Drugs